Evolving risks in continuous manufacturing
Making the switch to continuous creates new challenges for risk management and insurance coverage (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 28, 2019 Category: Pharmaceuticals Source Type: news
Mirum grabs breakthrough designation for liver drug
Mirum Pharmaceuticals announced that the U.S. FDA has granted Breakthrough Therapy Designation for maralixibat for the treatment of pruritus associated with Alagille syndrome (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 28, 2019 Category: Pharmaceuticals Source Type: news
Matching industrial networks to hardware
Getting industrial instrumentation to operate effectively on office networks can be frustrating, but WirelessHART can help (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 28, 2019 Category: Pharmaceuticals Source Type: news
GSK starts late-stage study for new-age antibiotic
GlaxoSmithKline has begun a late-stage study testing its experimental antibiotic, gepotidacin, in patients with urinary tract infections and gonorrhoea. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 28, 2019 Category: Pharmaceuticals Source Type: news
eBook: Pharma Innovation 2019
Discover the latest tech and systems that have changed the game in pharmaceutical manufacturing (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 25, 2019 Category: Pharmaceuticals Source Type: news
Allergan's Botox gets pediatric approval
Allergan announced that the U.S. FDA has approved the company ' s supplemental BLA for Botox for the treatment of pediatric patients (2 to 17 years of age) with lower limb spasticity, excluding spasticity caused by cerebral palsy. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 25, 2019 Category: Pharmaceuticals Source Type: news
Vertex, NHS England finally agree on Orkambi price
The National Health Service in England has finally approved Vertex ' s Orkambi to treat people with cystic fibrosis, after four years of deadlock over the price tag. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 25, 2019 Category: Pharmaceuticals Source Type: news
Pharma in review: trending stories 10/25/19
Most popular Pharma Manufacturing stories from the past seven days. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 25, 2019 Category: Pharmaceuticals Source Type: news
Amgen makes major price cut to Repatha
Amgen announced this week that it has slashed the price of its cholesterol med, Repatha, by 60 percent. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 24, 2019 Category: Pharmaceuticals Source Type: news
Pharma: Reluctant revolutionaries
The industry needs to rally behind digital if it wants to see real change (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 23, 2019 Category: Pharmaceuticals Source Type: news
Irish Novartis workers ‘shocked’ by layoff announcement
About 320 workers at a Novartis plant in Ringaskiddy, Ireland found out this week that their jobs are going to be cut. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 23, 2019 Category: Pharmaceuticals Source Type: news
Getting safety stock just right
Preventing drug shortages with cognitive automation (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 23, 2019 Category: Pharmaceuticals Source Type: news
Takeda acquires Cour celiac disease treatment for up to $420 million
The Japanese company has bought the exclusive global license to an immune modifying nanoparticle designed to induce tolerance to gluten in patients with celiac disease. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 22, 2019 Category: Pharmaceuticals Source Type: news
Vertex wins FDA approval for cystic fibrosis combo treatment
The pharma company has also priced the three-drug combination at more than $300,000 per year. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 22, 2019 Category: Pharmaceuticals Source Type: news
Biogen announces surprise submission for Alzheimer ’s drug approval
Biogen said it is now resurrecting its hope that the drug could become a blockbuster, and will seek FDA approval for the medication early next year. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 22, 2019 Category: Pharmaceuticals Source Type: news
